Studies have found that lung injury induces FSTL1 expression, which promotes myofibroblast accumulation and subsequent fibrosis, while blockade of FSTL1 with a neutralizing antibody can inhibit pulmonary fibrosis in mice [15]. Here, FSTL1 is linked to pulmonary fibrosis.